CVS Health Co. (NYSE:CVS) Shares Purchased by Caisse DE Depot ET Placement DU Quebec

Caisse DE Depot ET Placement DU Quebec boosted its position in shares of CVS Health Co. (NYSE:CVS - Free Report) by 4.1% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,082,145 shares of the pharmacy operator's stock after buying an additional 42,307 shares during the period. Caisse DE Depot ET Placement DU Quebec owned approximately 0.09% of CVS Health worth $68,045,000 at the end of the most recent quarter.

Other hedge funds also recently made changes to their positions in the company. Garland Capital Management Inc. grew its position in shares of CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock worth $3,591,000 after buying an additional 160 shares during the period. Sound Income Strategies LLC raised its stake in shares of CVS Health by 7.2% during the 3rd quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock worth $151,000 after purchasing an additional 162 shares during the period. Plimoth Trust Co. LLC raised its stake in CVS Health by 0.4% in the 2nd quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator's stock valued at $2,754,000 after acquiring an additional 174 shares during the period. Hexagon Capital Partners LLC increased its position in shares of CVS Health by 3.5% during the third quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock valued at $331,000 after buying an additional 178 shares during the period. Finally, Pallas Capital Advisors LLC grew its holdings in shares of CVS Health by 2.5% during the second quarter. Pallas Capital Advisors LLC now owns 7,458 shares of the pharmacy operator's stock worth $447,000 after purchasing an additional 183 shares in the last quarter. 80.66% of the stock is currently owned by institutional investors and hedge funds.

CVS Health Trading Down 0.2 %

Shares of CVS Health stock traded down $0.11 on Friday, reaching $59.85. The company had a trading volume of 3,947,743 shares, compared to its average volume of 12,709,454. The firm has a market cap of $75.32 billion, a price-to-earnings ratio of 15.19, a P/E/G ratio of 1.02 and a beta of 0.55. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. The firm's 50-day moving average price is $59.36 and its two-hundred day moving average price is $58.77. CVS Health Co. has a 1 year low of $52.71 and a 1 year high of $83.25.

CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. CVS Health had a return on equity of 10.72% and a net margin of 1.36%. The company had revenue of $95.43 billion during the quarter, compared to analysts' expectations of $92.72 billion. During the same quarter in the previous year, the business earned $2.21 EPS. CVS Health's revenue was up 6.3% compared to the same quarter last year. As a group, research analysts predict that CVS Health Co. will post 5.37 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a yield of 4.44%. The ex-dividend date of this dividend was Monday, October 21st. CVS Health's payout ratio is currently 67.51%.

Analysts Set New Price Targets

CVS has been the subject of a number of recent analyst reports. Wells Fargo & Company upgraded CVS Health from an "equal weight" rating to an "overweight" rating and upped their target price for the company from $60.00 to $66.00 in a report on Monday, November 18th. Truist Financial reissued a "buy" rating and issued a $67.00 target price (down from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. Piper Sandler cut their target price on CVS Health from $72.00 to $64.00 and set an "overweight" rating on the stock in a research note on Monday, November 25th. Royal Bank of Canada dropped their price objective on CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research report on Friday, November 15th. Finally, Evercore ISI increased their price objective on CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research report on Tuesday, October 8th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat, CVS Health presently has an average rating of "Moderate Buy" and an average price target of $70.33.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.